Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
309M
-
Number of holders
-
222
-
Total 13F shares, excl. options
-
277M
-
Shares change
-
+786K
-
Total reported value, excl. options
-
$2.67B
-
Value change
-
+$5.14M
-
Put/Call ratio
-
0.34
-
Number of buys
-
107
-
Number of sells
-
-114
-
Price
-
$9.64
Significant Holders of AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) as of Q2 2021
297 filings reported holding FOLD - AMICUS THERAPEUTICS, INC. - Common Stock as of Q2 2021.
AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) has 222 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 277M shares
of 309M outstanding shares and own 89.61% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (24.7M shares), PERCEPTIVE ADVISORS LLC (23.1M shares), Redmile Group, LLC (20.8M shares), BlackRock Inc. (20.3M shares), WELLINGTON MANAGEMENT GROUP LLP (15.7M shares), JPMORGAN CHASE & CO (13.3M shares), Avoro Capital Advisors LLC (12.5M shares), MORGAN STANLEY (11.7M shares), Palo Alto Investors LP (10M shares), and STATE STREET CORP (9.44M shares).
This table shows the top 222 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.